相关实验视频

Updated: Jun 6, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

揭示分子瘤板的数字演变

Sebastian Lutz¹, Alicia D'Angelo², Sonja Hammerl²

¹IT-Infrastructure for Translational Medical Research, University of Augsburg, Augsburg, Germany. sebastian.lutz@uni-a.de.

Targeted oncology

|November 28, 2024

概括

分子瘤板 (MTBs) 通过整合分子数据来简化癌症治疗. 这项研究审查了当前的MTB流程,知识库和数字工具,以改善个性化药物交付.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
医疗信息学医疗信息学

背景情况:

分子瘤板 (MTB) 对于个性化癌症治疗至关重要,它整合了各种数据以进行个性化治疗建议.
异质数据 (临床,基因组) 和外部资源 (数据库,文献) 的复杂性在MTB工作流程中提出了重大挑战.
在MTB中手动处理和分析数据是耗时的,需要大量的人力.

研究的目的:

对分子瘤板 (MTBs) 进行全面的文献审查.
分析当前的流程,共同的知识库和用于MTB决策的支持工具.
确定MTB工作流程中自动化和数字化的趋势.

主要方法:

在分子瘤板 (MTBs) 上进行系统的文献搜索.
分析现有的MTB流程,数据整合策略和知识管理系统.
审查支持MTB运营的数字工具和自动化解决方案.

主要成果:

大型治疗方案将患者的临床数据与分子变异整合为量身定制的治疗计划.
不同质的数据源需要大量的努力来实现同质化和快速分析.
越来越多地采用自动化和数字化来提高效率并减少MTB中的手工工作量.
工具有助于数据可视化,为董事会成员提供精细的概述.

结论:

自动化和数字化是优化MTB效率和减少个性化治疗建议的周转时间的关键.
多种数据源和知识库的有效整合对于成功的MTB操作至关重要.
持续开发支持工具对于完善分子瘤委员会决策流程至关重要.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...